Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Hungary Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20111
20123
20136
20142
20151
20163
20171
20181
20191
20211
20234
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
Sanofi6
Novartis Pharmaceuticals5
Merck Sharp & Dohme LLC3
Takeda2
AstraZeneca1
Kastle Therapeutics, LLC1
Regeneron Pharmaceuticals1
The Medicines Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia30
Dyslipidemias7
Hyperlipidemias7
Hyperlipoproteinemia Type II3
Cardiovascular Diseases2
Homozygous Familial Hypercholesterolemia2
Aortic Valve Stenosis1
Arteriosclerosis1
Atherosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.